Almost all patients with a group of blood cancers called B-cell malignancies have two prominent "fingerprints" on the surface of leukemia and lymphoma cancers, called CD22 and CD19, Vallera explained. To develop the drug, ...
Mar 13, 2015
0
8
A study released Dec. 23 describes a never-before-seen mechanism by which a bacterial toxin leads to severe inflammation in asthma and other acute and chronic pulmonary diseases. Researchers from The University of Texas Health ...
Dec 29, 2014
0
0
Researchers at Western University (London, Canada) have shown how the bacteria primarily responsible for causing strep throat can be used to fight colon cancer. By engineering a streptococcal bacterial toxin to attach itself ...
May 20, 2014
0
0
There has been a small outbreak of E. coli infection in Brisbane. Three children and one adult who attended the Brisbane Royal Agricultural Show, also known as Ekka, tested positive for the bacterial infection last week.
Aug 27, 2013
0
0
New research reveals how the most common cause of severe allergic reactions to cats, the Fel d 1 protein which is found in cat dander, triggers an allergic response.
Jul 25, 2013
0
0
(Medical Xpress)—The United States is on track to have its biggest whooping cough epidemic in 60 years, with more than 21,000 cases already reported in 2012. The highly contagious and potentially fatal disease, officially ...
Aug 27, 2012
0
0
When hospital patients need assistance breathing and are placed on a mechanical ventilator for days at a time, their lungs react to the pressure generated by the ventilator with an out-of-control immune response that can ...
Jul 18, 2012
0
0
A team of researchers at the Hebrew University of Jerusalem says it has found a way to block a group of fatal bacterial toxins that have to date resisted all attempts to arrest them through the use of conventional drugs.
Sep 13, 2011
1
0
Babies and toddlers with congenital heart disease are at an increased risk of having harmful toxins in their blood, particularly following surgery, according to research by a team at Imperial College London.
Aug 26, 2011
0
0
Patients with HER2-positive breast cancer may soon have an alternative therapy when they develop resistance to trastuzumab, also known as Herceptin, according to a laboratory finding published in Clinical Cancer Research.
Jul 26, 2011
0
0
